Stay updated on Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe clinical trial record for KEYNOTE-062 is now displayed, including its study design, eligibility criteria, treatment arms, outcome measures, publications, and record dates.SummaryDifference66%

- Check14 days agoChange DetectedThe displayed site revision identifier changed from v3.7.2 to v3.8.0 on the 403 error page.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the study record content with an error screen. Navigation and related study details are no longer visible.SummaryDifference21%

Stay in the know with updates to Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.